Rapidly Progressive Weakness With Bulbar Symptoms
A 6-year-old boy presents with 5 days of progressive symmetric weakness. He had diarrhea 10 days ago. He can no longer climb stairs, and his parents report nasal speech and choking on liquids. Examination shows symmetric flaccid weakness, areflexia, intact sensation, and no fever. Vital capacity is 55% of predicted, negative inspiratory force is -25 cm H2O, and single-breath count is 18. Cerebrospinal fluid shows protein 65 mg/dL with 2 white blood cells/µL; nerve conduction shows prolonged F waves and reduced compound muscle action potentials. He is admitted to the general ward because oxygen saturation is 98% on room air.
1. Should this child be managed on the general ward or in intensive care? What specific respiratory parameters drive your decision?
Read the worked answer
He should be managed in a high-dependency or intensive care setting, not a general ward. Oxygen saturation is a late and insensitive marker in neuromuscular respiratory failure; patients can have normal saturation until immediate respiratory collapse. The concerning features are bulbar dysfunction with choking, nasal speech, a negative inspiratory force of -25 cm H2O, a single-breath count of 18, and vital capacity at 55% of predicted with a rapidly progressive course. I would monitor vital capacity, negative inspiratory force, and single-breath count every 4 hours, and more often if trends worsen. Intubation should be anticipated if vital capacity falls below 15–20 mL/kg, negative inspiratory force weakens beyond -30 cm H2O, or bulbar weakness impairs secretion clearance. Autonomic instability and aspiration risk also support intensive monitoring.
2. What is the role of IVIG versus plasma exchange, and what medication should be avoided?
Read the worked answer
IVIG and plasma exchange are both effective for Guillain-Barré syndrome and are considered equivalent first-line immunomodulatory treatments. The choice depends on access, hemodynamic stability, and ability to place lines. IVIG 2 g/kg over 2–5 days is often used in children; plasma exchange is an alternative, especially if IVIG is unavailable or the patient is deteriorating. Corticosteroids are not recommended and may worsen outcomes. I would also avoid succinylcholine because of the risk of hyperkalemia in denervated muscle, and I would avoid unnecessary intramuscular injections in a child with evolving coagulopathy or autonomic instability. Supportive care, aspiration precautions, and respiratory monitoring matter as much as immunotherapy.
3. On day 10 he worsens after completing IVIG. What are the options, and how do you counsel about prognosis?
Read the worked answer
Worsening after IVIG can represent the natural nadir of Guillain-Barré syndrome rather than treatment failure. I would first reassess for complications: aspiration, atelectasis, hospital-acquired infection, autonomic instability, and venous thromboembolism. If the weakness is clearly progressive and respiratory parameters are declining, I would consider a second course of IVIG or plasma exchange, but not corticosteroids. The family should be counseled that most children walk independently by 6 months, but recovery can take 6–12 months, and 10–20% have residual fatigue, weakness, or areflexia. I would emphasize rehabilitation, school planning, and monitoring for relapse, which is uncommon but possible. The key judgment is to distinguish expected progression from a treatable complication before escalating immunotherapy.